Mast-Cell Stabilizing Effects of Olopatadine

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To assess the effects of olopatadine of the release of mast cell histamine

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Alcon Research
• Treatments: Olopatadine Hydrochloride

Criteria

Inclusion Criteria:

• Asymptomatic and not using any topical or systemic medication

Exclusion Criteria:

• Age